STAY ALIVE WITH RIVIVE
Live / Registered — Registered (as of 16 Jun 2026)
What this means for you
Registered since 16 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Jun 2032: the §8 declaration of use).
Record
- Serial number
- 98804272
- Registration number
- 8306772
- Mark type
- Slogan / phrase
- Filed
- 16 Oct 2024
- Published for opposition
- 06 May 2025
- Registered
- 16 Jun 2026
- Next maintenance filing
- §8 declaration of use, due by 16 Jun 2032 (grace period to 16 Dec 2032)
- Attorney of record
- Joseph W. Berenato, III
Goods and services
- Class 005 — Pharmaceuticals: Intra-nasal sprays containing naloxone for medical purposes
Owner
- Harm Reduction Therapeutics, Inc., Bethesda, MD, US
- Harm Reduction Therapeutics, Inc., Bethesda, MD, US
- Harm Reduction Therapeutics, Inc., Bethesda, MD, US
Prosecution history
- 16 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 28 May 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 May 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Dec 2025 — USE AMENDMENT FILED
- 04 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Jul 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 13 Jul 2025 — ASSIGNED TO PETITION STAFF
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 May 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED